present
investig
patient
enrol
hospitalbas
prospect
cohort
studi
patient
underw
bal
elig
irrespect
reason
lead
procedur
lung
transplant
recipi
studi
conduct
site
transplant
network
univers
hospit
geneva
geneva
switzerland
univers
hospit
lausann
lausann
switzerland
bal
perform
accord
guidelin
follow
patient
immunocompromis
patient
persist
infiltr
visibl
chest
radiograph
despit
largespectrum
antibiot
treatment
hivinfect
patient
low
cell
count
interstiti
infiltr
suspect
pulmonari
opportunist
infect
patient
suspect
pulmonari
tuberculosi
whose
sputum
analysi
neg
find
patient
persist
diffus
interstiti
infiltr
unknown
origin
exacerb
symptom
patient
chronic
interstiti
diseas
nosocomi
pneumonia
exacerb
symptom
includ
patient
intub
treat
widespectrum
antibiot
without
respons
tumorlik
abnorm
lung
transplant
recipi
bal
also
perform
followup
diagnost
procedur
either
follow
transplant
organ
reject
suspect
antireject
treatment
thu
lung
transplant
recipi
could
sever
bal
perform
followup
period
patient
consid
immunosuppress
receiv
treatment
antireject
drug
receiv
chemotherapi
regardless
neutropenia
receiv
steroid
mg
per
day
least
week
bal
procedur
hiv
infect
cell
count
bal
fluid
specimen
patient
screen
rtpcr
presenc
coronavirus
known
infect
human
hcov
hcov
hcov
hcov
well
addit
respiratori
virus
influenza
b
virus
respiratori
syncyti
virus
b
human
parainfluenza
virus
human
rhinoviru
enteroviru
human
metapneumoviru
presenc
mycoplasma
pneumonia
chlamydophila
pneumonia
legionella
pneumophila
also
determin
pcr
shortli
bal
procedur
perform
baselin
case
report
form
complet
physician
blind
microbiolog
test
result
inform
record
includ
underli
diseas
presenc
fever
type
durat
respiratori
symptom
respons
antimicrobi
andor
antivir
therapi
reason
bal
procedur
presum
diagnosi
determin
basi
avail
evid
time
three
day
bal
procedur
followup
case
report
form
complet
assess
symptom
evolut
respons
treatment
new
chest
radiographi
find
avail
result
microbiolog
test
followup
day
perform
assess
outcom
final
diagnosi
record
data
addit
microbiolog
test
andor
patholog
examin
avail
patient
includ
particular
analysi
coronaviru
infect
also
perform
addit
review
medic
file
avail
collect
addit
inform
descript
evolut
caus
clinic
symptom
bal
perform
accord
standard
protocol
ml
steril
salin
solut
instil
time
distal
bronchial
tree
either
radiograph
site
chest
abnorm
middl
lobe
bal
fluid
specimen
initi
pool
separ
aliquot
process
similarli
subsequ
analysi
gram
acridin
orang
truant
auraminerhodamin
giemsa
stain
perform
direct
identif
bacteria
mycobacteria
fungi
parasit
respect
cultur
bacteri
identif
inocul
standard
aerob
condit
onto
differ
media
well
onto
specif
media
mycobacterium
detect
indic
clinic
condit
pulmonari
bacteri
infect
consid
proven
quantit
cultur
given
bacteria
yield
colonyform
unit
per
ml
specimen
associ
clinic
radiolog
symptom
condit
met
cultur
consid
indic
colon
bal
fluid
specimen
inocul
differ
cell
line
viral
detect
human
embryon
fibroblast
mdck
cell
aliquot
immedi
frozen
use
duplic
rtpcr
pcr
assay
realtim
taqman
rtpcr
assay
detect
influenza
b
virus
respiratori
syncyti
virus
b
human
parainfluenza
virus
human
rhinoviru
enteroviru
human
metapneumoviru
perform
describ
elsewher
brief
rna
extract
bal
fluid
specimen
hcv
amplicor
specimen
prepar
kit
roch
diagnost
retrotranscript
perform
use
superscripttm
ii
rnase
transcriptas
invitrogen
life
technolog
random
primer
pd
n
roch
diagnost
gmbh
amplif
detect
perform
use
abi
prism
ht
appli
biosystem
differ
step
extract
retrotranscript
conduct
parallel
known
posit
supernat
human
rhinoviru
cell
appropri
neg
control
forward
primer
revers
primer
probe
use
detect
coronavirus
describ
elsewher
complet
analysi
rtpcr
target
hcov
use
similar
pcr
condit
control
assay
use
pair
pcr
product
genbank
access
number
forward
primer
ttt
tgt
tgt
tca
cat
ggt
gat
revers
primer
use
acc
gcc
aca
cat
aac
tat
probe
ttt
atc
gcc
ttg
cga
atg
aat
gtg
ctc
valid
experi
use
abovement
pcr
product
pcr
target
show
analyt
sensit
pcr
assay
studi
approv
ethic
committe
univers
hospit
geneva
geneva
switzerland
univers
hospit
lausann
lausann
switzerland
inform
sign
consent
form
obtain
particip
period
analyz
bal
fluid
specimen
obtain
patient
enrol
studi
median
length
enrol
month
rang
month
mean
age
year
patient
male
among
bal
fluid
specimen
examin
lung
transplant
recipi
patient
treat
immunosuppress
therapi
hivinfect
patient
patient
immunosuppress
condit
hcov
identifi
bal
fluid
specimen
wherea
bal
fluid
specimen
result
neg
hcov
result
posit
respiratori
virus
overal
specimen
test
result
posit
respiratori
viru
among
hcovposit
specimen
hcov
frequent
speci
isol
specimen
follow
specimen
specimen
specimen
median
age
patient
hcovposit
specimen
obtain
year
rang
year
male
transplant
frequent
underli
condit
patient
lung
transplant
recipi
also
receiv
liver
transplant
patient
consid
immunosuppress
baselin
characterist
comorbid
describ
tabl
bal
perform
ambulatori
patient
other
hospit
median
durat
day
rang
day
time
procedur
patient
receiv
antibiot
treatment
nine
patient
hospit
intens
care
unit
time
bal
procedur
receiv
mechan
ventil
reason
lead
perform
bal
procedur
given
tabl
time
bal
acut
respiratori
symptom
andor
new
chest
abnorm
visibl
radiograph
present
patient
hcov
infect
patient
present
acut
respiratori
symptom
present
cough
andor
sputum
present
dyspnea
new
abnorm
visibl
chest
radiograph
document
patient
abnorm
includ
interstiti
infiltr
patient
alveolar
local
infiltr
pleural
effus
pneumothorax
mean
cell
count
bal
fluid
specimen
cellsml
rang
cellsml
neutrophil
rang
lymphocyt
rang
sixteen
patient
alreadi
receiv
treatment
respiratori
infect
time
bal
patient
antibiot
therapi
modifi
followup
period
patient
antibiot
therapi
start
immedi
follow
bal
patient
receiv
diagnosi
acut
lower
respiratori
tract
infect
hospit
discharg
tabl
patient
microbiolog
test
result
bal
specimen
neg
typic
bacteria
test
standard
cultur
atyp
bacteria
test
pcr
well
respiratori
virus
herpesvirus
note
patient
receiv
antibiot
treatment
time
provid
bal
fluid
specimen
remain
patient
microbiolog
test
result
posit
typic
atyp
bacteria
respiratori
virus
herpesvirus
patient
receiv
antibiot
treatment
ci
bacterium
like
caus
infect
isol
sampl
obtain
patient
patient
receiv
diagnosi
pneumocysti
jirovecii
pneumonia
herp
simplex
viru
cytomegaloviru
isol
sampl
patient
consid
caus
respiratori
symptom
screen
respiratori
virus
posit
result
patient
coinfect
human
rhinoviru
respiratori
syncyti
viru
coinfeciton
patient
outcom
avail
patient
lost
followup
transfer
hospit
outsid
switzerland
day
respect
overal
mortal
rate
day
death
two
patient
chronic
pulmonari
diseas
pulmonari
fibrosi
lung
cancer
die
respiratori
failur
day
respect
patient
die
heart
failur
day
one
patient
infect
hcov
infect
hcov
opportun
analyz
bal
fluid
specimen
obtain
patient
hcov
infect
lung
transplant
recipi
patient
known
hcov
infect
median
bal
fluid
specimen
per
patient
rang
specimen
median
followup
durat
week
rang
week
screen
coronavirus
neg
result
patient
patient
hiv
infect
cell
count
develop
p
jirovecii
pneumonia
persist
abnorm
visibl
chest
radiograph
despit
week
treatment
sulfamethoxazol
result
cultur
bal
fluid
sampl
obtain
week
still
posit
hcov
bal
procedur
conduct
perform
cold
season
autumn
winter
perform
rest
year
season
distribut
case
hcov
infect
significantli
higher
cold
season
case
compar
rest
year
case
p
analyz
result
cultur
bal
fluid
specimen
obtain
patient
acut
respiratori
tract
ill
prospect
hospitalbas
cohort
adult
patient
specimen
analyz
identifi
demonstr
hcov
infect
interestingli
speci
hcov
present
classic
type
compris
isol
new
type
compris
infect
due
illustr
potenti
role
impact
newli
discov
viru
type
highlight
need
continu
adapt
diagnost
tool
new
speci
case
ill
presenc
clinic
sign
abnorm
visibl
chest
radiograph
mainli
interstiti
infiltr
compat
diagnosi
acut
viral
respiratori
tract
infect
prompt
perform
bal
antibiot
given
patient
perform
bal
limit
effect
clinic
failur
prompt
switch
antibiot
treatment
patient
addit
hcov
infecti
agent
identifi
case
result
microbiolog
test
neg
similarli
bacteriolog
test
result
also
neg
patient
treat
antibiot
underw
bal
suggest
patient
hcov
infect
lead
caus
symptom
led
perform
bal
seriou
associ
comorbid
andor
immunocompromis
condit
could
promot
lower
respiratori
viral
complic
also
present
patient
final
studi
design
provid
opportun
analyz
addit
bal
sampl
obtain
andor
ill
due
hcov
infect
enrol
patient
sampl
neg
coronaviru
demonstr
viru
present
acut
phase
respiratori
symptom
led
bal
asymptomat
colon
observ
strongli
suggest
substanti
number
patient
hcov
play
role
andor
promot
lower
respiratori
diseas
observ
coronavirus
shown
associ
lower
respiratori
tract
complic
complic
mostli
affect
children
knowledg
studi
either
prospect
analyz
larg
number
adult
patient
analyz
hcov
caus
infect
patient
high
risk
complic
one
studi
perform
retrospect
involv
bone
marrow
transplant
recipi
fail
detect
hcov
store
bal
fluid
specimen
differ
result
might
explain
sever
factor
patient
select
basi
need
basi
predefin
clinic
criteria
focu
select
subgroup
patient
winter
season
cover
sensit
realtim
rtpcr
assay
target
hcov
perform
prospect
design
investig
therefor
avoid
mani
limit
observ
retrospect
studi
give
estim
impact
coronavirus
among
patient
hospit
seriou
chronic
andor
immunosuppress
condit
sinc
first
welldefin
case
hcov
infect
document
incid
infect
due
respect
role
hcov
hcov
among
adult
popul
assess
systemat
manner
hcov
similar
virus
caus
respiratori
diseas
studi
mostli
retrospect
seri
analys
store
specimen
collect
children
larg
seri
preval
hcov
infect
rang
one
largest
studi
retrospect
test
nasopharyng
aspir
hospitalbas
pediatr
popul
acut
respiratori
diseas
found
children
hcov
infect
children
present
lower
respiratori
tract
symptom
requir
hospit
anoth
studi
specimen
children
symptom
lower
andor
upper
respiratori
infect
identifi
specimen
posit
hcov
design
new
close
relat
children
present
infiltr
visibl
chest
radiograph
substanti
number
children
hospit
critic
condit
taken
togeth
data
strongli
suggest
associ
hcov
lower
respiratori
tract
diseas
children
sinc
first
descript
elderli
man
pneumonia
adult
case
infect
due
hcov
report
among
rescreen
popul
case
diagnos
screen
respiratori
sampl
sent
viral
analysi
anoth
studi
woo
et
al
conduct
sar
outbreak
hong
kong
nasopharyng
aspir
collect
patient
communityacquir
pneumonia
abnorm
visibl
chest
radiograph
subsequ
screen
woo
colleagu
found
case
hcov
infect
occur
adult
review
patient
medic
chart
show
approxim
onehalf
patient
chronic
lung
diseas
hospit
requir
patient
patient
die
find
consist
previou
investig
demonstr
hcov
also
detect
lower
respiratori
tract
specimen
obtain
adult
provid
comparison
respect
role
caus
ill
season
studi
conduct
less
frequent
identifi
classic
speci
nevertheless
contribut
significantli
overal
spectrum
coronavirusassoci
diseas
among
hospit
adult
patient
larg
subgroup
patient
emerg
analysi
lung
transplant
recipi
recent
report
regard
popul
suggest
link
viral
respiratori
tract
infect
graft
dysfunct
bronchiol
obliteran
syndrom
howev
studi
coronavirus
investig
need
use
inhous
updat
pcr
assay
patient
main
final
diagnosi
lower
respiratori
tract
infect
andor
acut
respiratori
symptom
unspecifi
etiolog
despit
extens
routin
investig
support
hypothesi
coronaviru
infect
promot
lower
respiratori
tract
diseas
observ
patient
conclus
present
prospect
studi
provid
comprehens
analysi
potenti
impact
hcov
caus
infect
among
hospitalbas
patient
overal
coronavirus
recov
bal
fluid
specimen
analyz
hcov
infect
commonli
observ
patient
high
risk
respiratori
complic
includ
lung
transplant
recipi
recent
discov
speci
hcov
hcov
contribut
significantli
spectrum
hcovassoci
diseas
studi
